ETF Building Blocks Content Hub A Healthcare ETF Could Benefit From Index Reshuffling By Tom LydonJune 23, 2020
ETF Building Blocks Content Hub Biotech ETF Doesn’t Need Coronavirus Vaccines to Soar By Tom LydonJune 2, 2020
Beyond Basic Beta Content Hub Biotech Benefits as Companies Race to Cure Coronavirus By Tom LydonMay 26, 2020
Featured Biotech ETFs Stable Despite Disappointing Treatment Date From Gilead By Ian YoungApril 23, 2020
Beyond Basic Beta Content Hub Biotech ETFs Brush Off Political Attacks on Drug Prices By Tom LydonJanuary 21, 2020
Innovative ETFs Content Hub Biotech ETFs Strengthen as Amgen Invests in China’s BeiGene By Max ChenNovember 1, 2019
Beyond Basic Beta Content Hub Biotech ETFs Had A Rough Third Quarter By Todd ShriberSeptember 30, 2019
Beyond Basic Beta Content Hub Biotech ETFs Could Use Some Mergers & Acquisitions By Tom LydonMay 17, 2019
Equity ETFs Biotech ETFs Rally as Pence Promises ‘Orderly Transition’ Away from Obamacare By Max ChenJanuary 4, 2017
